385 related articles for article (PubMed ID: 25416535)
1. Vancomycin population pharmacokinetics during extracorporeal membrane oxygenation therapy: a matched cohort study.
Donadello K; Roberts JA; Cristallini S; Beumier M; Shekar K; Jacobs F; Belhaj A; Vincent JL; de Backer D; Taccone FS
Crit Care; 2014 Nov; 18(6):632. PubMed ID: 25416535
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of vancomycin in adults receiving extracorporeal membrane oxygenation.
Wu CC; Shen LJ; Hsu LF; Ko WJ; Wu FL
J Formos Med Assoc; 2016 Jul; 115(7):560-70. PubMed ID: 26123638
[TBL] [Abstract][Full Text] [Related]
3. The combined effects of extracorporeal membrane oxygenation and renal replacement therapy on meropenem pharmacokinetics: a matched cohort study.
Shekar K; Fraser JF; Taccone FS; Welch S; Wallis SC; Mullany DV; Lipman J; Roberts JA;
Crit Care; 2014 Dec; 18(6):565. PubMed ID: 25636084
[TBL] [Abstract][Full Text] [Related]
4. Trough Concentrations of Vancomycin in Patients Undergoing Extracorporeal Membrane Oxygenation.
Park SJ; Yang JH; Park HJ; In YW; Lee YM; Cho YH; Chung CR; Park CM; Jeon K; Suh GY
PLoS One; 2015; 10(11):e0141016. PubMed ID: 26544074
[TBL] [Abstract][Full Text] [Related]
5. Vancomycin pharmacokinetics in neonates receiving extracorporeal membrane oxygenation.
Buck ML
Pharmacotherapy; 1998; 18(5):1082-6. PubMed ID: 9758319
[TBL] [Abstract][Full Text] [Related]
6. Population Pharmacokinetics of Vancomycin in Critically Ill Adult Patients Receiving Extracorporeal Membrane Oxygenation (an ASAP ECMO Study).
Cheng V; Abdul-Aziz MH; Burrows F; Buscher H; Cho YJ; Corley A; Diehl A; Gilder E; Jakob SM; Kim HS; Levkovich BJ; Lim SY; McGuinness S; Parke R; Pellegrino V; Que YA; Reynolds C; Rudham S; Wallis SC; Welch SA; Zacharias D; Fraser JF; Shekar K; Roberts JA;
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0137721. PubMed ID: 34633852
[TBL] [Abstract][Full Text] [Related]
7. Vancomycin pharmacokinetics in critically ill neonates receiving extracorporeal membrane oxygenation.
An SH; Lee EM; Kim JY; Gwak HS
Eur J Hosp Pharm; 2020 Mar; 27(e1):e25-e29. PubMed ID: 32296501
[TBL] [Abstract][Full Text] [Related]
8. Population Pharmacokinetics of Vancomycin in Pediatric Extracorporeal Membrane Oxygenation.
Moffett BS; Morris J; Galati M; Munoz F; Arikan AA
Pediatr Crit Care Med; 2018 Oct; 19(10):973-980. PubMed ID: 30063652
[TBL] [Abstract][Full Text] [Related]
9. Incremental research approach to describing the pharmacokinetics of ciprofloxacin during extracorporeal membrane oxygenation.
Sinnah F; Shekar K; Abdul-Aziz MH; Buscher H; Diab SD; Fisquet S; Fung YL; McDonald CI; Reynolds C; Rudham S; Wallis SC; Welch S; Xie J; Fraser JF; Roberts JA;
Crit Care Resusc; 2017 Oct; 19(Suppl 1):8-14. PubMed ID: 29084496
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic Assessment of Pre- and Post-Oxygenator Vancomycin Concentrations in Extracorporeal Membrane Oxygenation: A Prospective Observational Study.
Mahmoud AA; Avedissian SN; Al-Qamari A; Bohling T; Pham M; Scheetz MH
Clin Pharmacokinet; 2020 Dec; 59(12):1575-1587. PubMed ID: 32468446
[TBL] [Abstract][Full Text] [Related]
11. A Population Pharmacokinetic Model for Vancomycin in Adult Patients Receiving Extracorporeal Membrane Oxygenation Therapy.
Moore JN; Healy JR; Thoma BN; Peahota MM; Ahamadi M; Schmidt L; Cavarocchi NC; Kraft WK
CPT Pharmacometrics Syst Pharmacol; 2016 Sep; 5(9):495-502. PubMed ID: 27639260
[TBL] [Abstract][Full Text] [Related]
12. Effect of Extracorporeal Membrane Oxygenation on the New Vancomycin Dosing Regimen in Critically Ill Patients Receiving Continuous Venovenous Hemofiltration.
Yang CJ; Wu CW; Wu CC
Ther Drug Monit; 2018 Jun; 40(3):310-314. PubMed ID: 29746432
[TBL] [Abstract][Full Text] [Related]
13. Population Pharmacokinetics and Dosing Simulations of Ceftriaxone in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation (An ASAP ECMO Study).
Cheng V; Abdul-Aziz MH; Burrows F; Buscher H; Cho YJ; Corley A; Gilder E; Kim HS; Lim SY; McGuinness S; Parke R; Reynolds C; Rudham S; Wallis SC; Welch SA; Fraser JF; Shekar K; Roberts JA;
Clin Pharmacokinet; 2022 Jun; 61(6):847-856. PubMed ID: 35253107
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics of cefepime in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study).
Cheng V; Abdul-Aziz MH; Burrows F; Buscher H; Corley A; Diehl A; Jakob SM; Levkovich BJ; Pellegrino V; Que YA; Reynolds C; Rudham S; Wallis SC; Welch SA; Zacharias D; Roberts JA; Shekar K; Fraser JF
Int J Antimicrob Agents; 2021 Dec; 58(6):106466. PubMed ID: 34688834
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of vancomycin in patients receiving extracorporeal membrane oxygenation.
Mulla H; Pooboni S
Br J Clin Pharmacol; 2005 Sep; 60(3):265-75. PubMed ID: 16120065
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics of intravenous sufentanil in critically ill patients supported with extracorporeal membrane oxygenation therapy.
Hahn J; Yang S; Min KL; Kim D; Jin BH; Park C; Park MS; Wi J; Chang MJ
Crit Care; 2019 Jul; 23(1):248. PubMed ID: 31288863
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patients.
Hahn J; Choi JH; Chang MJ
J Clin Pharm Ther; 2017 Dec; 42(6):661-671. PubMed ID: 28948652
[TBL] [Abstract][Full Text] [Related]
18. Influence of venovenous extracorporeal membrane oxygenation on pharmacokinetics of vancomycin in lung transplant recipients.
Liu D; Chen W; Wang Q; Li M; Zhang Z; Cui G; Li P; Zhang X; Ma Y; Zhan Q; Wang C
J Clin Pharm Ther; 2020 Oct; 45(5):1066-1075. PubMed ID: 32542736
[TBL] [Abstract][Full Text] [Related]
19. Population Pharmacokinetics and Pharmacodynamic Target Attainment of Vancomycin in Neonates on Extracorporeal Life Support.
Cies JJ; Moore WS; Nichols K; Knoderer CA; Carella DM; Chopra A
Pediatr Crit Care Med; 2017 Oct; 18(10):977-985. PubMed ID: 28650363
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of ciprofloxacin in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study).
Cheng V; Abdul-Aziz MH; Burrows F; Buscher H; Corley A; Diehl A; Levkovich BJ; Pellegrino V; Reynolds C; Rudham S; Wallis SC; Welch SA; Roberts JA; Shekar K; Fraser JF;
Anaesth Crit Care Pain Med; 2022 Jun; 41(3):101080. PubMed ID: 35472580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
